English

Synovics Pharmaceuticals

EDGAR

Quarterly report (10-Q) · filed 2009-09-21

49 filing records in this dataset, filed from 1997-05-30 to 2009-09-21. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.58 million USD

2009-07-31 · USD

Exact inputs and evidence

Revenue: 1578332 USD Source

Operating margin

-117.78%

2009-07-31 · %

Exact inputs and evidence

Operating Income: -1859030 USD Source
Revenue: 1578332 USD Source

Cash and cash equivalents: 130 thousand USD 2009-07-31 Source
Exact value

129860 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

19.1 million USD

2008-08-01 – 2009-07-31

Exact inputs and evidence

Revenue: 25959579 USD · 2007-11-01 – 2008-10-31 Source
Revenue: 18092122 USD · 2007-11-01 – 2008-07-31 Source
Revenue: 6836279 USD · 2008-11-01 – 2009-01-31 Source
Revenue: 2809430 USD · 2009-02-01 – 2009-04-30 Source
Revenue: 1578332 USD · 2009-05-01 – 2009-07-31 Source

Operating cash flow

-3.68 million USD

2006-11-01 – 2007-10-31

Exact inputs and evidence

Operating cash flow: 137017 USD · 2006-11-01 – 2007-01-31 Source
Operating cash flow: -915446 USD · 2006-11-01 – 2007-04-30 Source
Operating cash flow: 137017 USD · 2006-11-01 – 2007-01-31 Source
Operating cash flow: -2062548 USD · 2006-11-01 – 2007-07-31 Source
Operating cash flow: -915446 USD · 2006-11-01 – 2007-04-30 Source
Operating cash flow: -3683386 USD · 2006-11-01 – 2007-10-31 Source
Operating cash flow: -2062548 USD · 2006-11-01 – 2007-07-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-09-21.

Financial data available through: 2008-10-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2008-10-31
Operating income: 6 of 11 periods available· newest 2008-10-31
Net income: 6 of 11 periods available· newest 2008-10-31
Operating cash flow: 5 of 11 periods available· newest 2007-10-31
Capital expenditure: 5 of 11 periods available· newest 2008-10-31
Total assets: 5 of 11 periods available· newest 2008-10-31
Total liabilities: 4 of 11 periods available· newest 2008-10-31
Current assets: 6 of 11 periods available· newest 2008-10-31
Current liabilities: 6 of 11 periods available· newest 2008-10-31
Cash and cash equivalents: 6 of 11 periods available· newest 2008-10-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+10.6%

Prior period

USD 23.47 million

2006-11-01 – 2007-10-31
Current period

USD 25.96 million

2007-11-01 – 2008-10-31

Exact inputs and evidence

25959579 − 23466311 = 2493268 USD

23466311 USD · 2006-11-01 – 2007-10-31
Inspect prior input Prior source
25959579 USD · 2007-11-01 – 2008-10-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Synovics Pharmaceuticals · 2008-10-31 Synovics Pharmaceuticals (edgar:1030839) Year-over-year change in Revenue: 2493268 USD Concept: fundies:Revenue Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 25959579 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#15125 Input fundies:Revenue: 23466311 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#15125
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 16.85 million

Prior period

−USD 20.86 million

2006-11-01 – 2007-10-31
Current period

−USD 4.01 million

2007-11-01 – 2008-10-31

Exact inputs and evidence

-4005831 − -20857884 = 16852053 USD

-20857884 USD · 2006-11-01 – 2007-10-31
Inspect prior input Prior source
-4005831 USD · 2007-11-01 – 2008-10-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Synovics Pharmaceuticals · 2008-10-31 Synovics Pharmaceuticals (edgar:1030839) Year-over-year change in Net income: 16852053 USD Concept: fundies:NetIncome Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -4005831 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#17938 Input fundies:NetIncome: -20857884 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#17938
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-0.2%

Prior period

USD 709,593

2006-11-01 – 2007-10-31
Current period

USD 708,305

2007-11-01 – 2008-10-31

Exact inputs and evidence

708305 − 709593 = -1288 USD

709593 USD · 2006-11-01 – 2007-10-31
Inspect prior input Prior source
708305 USD · 2007-11-01 – 2008-10-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Synovics Pharmaceuticals · 2008-10-31 Synovics Pharmaceuticals (edgar:1030839) Year-over-year change in Capital expenditure: -1288 USD Concept: fundies:CapitalExpenditure Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 708305 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#18266 Input fundies:CapitalExpenditure: 709593 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#18266
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2007-11-01 – 2008-10-31

Revenue USD 25.96 million 100% of revenue
Cost of revenue USD 16.99 million 65% of revenue
Operating expenses USD 11.45 million 44% of revenue
Other operating costs Derived USD 660,920 2.5% of revenue
Operating income −USD 3.14 million −12% of revenue
Tax, interest and other Derived USD 861,446 3.3% of revenue
Net income −USD 4.01 million −15% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure USD 708,305 2.7% of revenue
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2003 Operating loss: operating costs were 111% of revenue.
2004 Operating loss: operating costs were 896% of revenue.
2005 Operating loss: operating costs were 23,435% of revenue.
2006 Operating loss: operating costs were 134% of revenue.
2007 Operating loss: operating costs were 161% of revenue.
2008 Operating loss: operating costs were 112% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2003 2002-11-01 – 2003-10-31	3094072	3441749 Derived	-347677	684776 Derived	-1032453	Unavailable	Source 2002-11-01 – 2003-10-31: 3094072 USD Inspect Revenue Open source 2002-11-01 – 2003-10-31: -347677 USD Inspect Operating Income Open source 2002-11-01 – 2003-10-31: -1032453 USD Inspect Net Income Open source 2002-11-01 – 2003-10-31: -324361 USD Inspect Operating Cash Flow Open source
2004 2003-11-01 – 2004-10-31	98767	885182 Derived	-786415	337921 Derived	-1124336	-643896 Derived	Source 2003-11-01 – 2004-10-31: 98767 USD Inspect Revenue Open source 2003-11-01 – 2004-10-31: -786415 USD Inspect Operating Income Open source 2003-11-01 – 2004-10-31: -1124336 USD Inspect Net Income Open source 2003-11-01 – 2004-10-31: -640397 USD Inspect Operating Cash Flow Open source 2003-11-01 – 2004-10-31: 3499 USD Inspect Capital Expenditure Open source
2005 2004-11-01 – 2005-10-31	8192	1919757 Derived	-1911565	999695 Derived	-2911260	-2495895 Derived	Source 2004-11-01 – 2005-10-31: 8192 USD Inspect Revenue Open source 2004-11-01 – 2005-10-31: -1911565 USD Inspect Operating Income Open source 2004-11-01 – 2005-10-31: -2911260 USD Inspect Net Income Open source 2004-11-01 – 2005-10-31: -2258086 USD Inspect Operating Cash Flow Open source 2004-11-01 – 2005-10-31: 237809 USD Inspect Capital Expenditure Open source
2006 2005-11-01 – 2006-10-31	10516398	14135584 Derived	-3619186	4951835 Derived	-8571021	-5613364 Derived	Source 2005-11-01 – 2006-10-31: 10516398 USD Inspect Revenue Open source 2005-11-01 – 2006-10-31: -3619186 USD Inspect Operating Income Open source 2005-11-01 – 2006-10-31: -8571021 USD Inspect Net Income Open source 2005-11-01 – 2006-10-31: -5165425 USD Inspect Operating Cash Flow Open source 2005-11-01 – 2006-10-31: 447939 USD Inspect Capital Expenditure Open source
2007 2006-11-01 – 2007-10-31	23466311	37737168 Derived	-14270857	6587027 Derived	-20857884	-4392979 Derived	Source 2006-11-01 – 2007-10-31: 23466311 USD Inspect Revenue Open source 2006-11-01 – 2007-10-31: -14270857 USD Inspect Operating Income Open source 2006-11-01 – 2007-10-31: -20857884 USD Inspect Net Income Open source 2006-11-01 – 2007-10-31: -3683386 USD Inspect Operating Cash Flow Open source 2006-11-01 – 2007-10-31: 709593 USD Inspect Capital Expenditure Open source
2008 2007-11-01 – 2008-10-31	25959579	29103964 Derived	-3144385	861446 Derived	-4005831	Unavailable	Source 2007-11-01 – 2008-10-31: 25959579 USD Inspect Revenue Open source 2007-11-01 – 2008-10-31: -3144385 USD Inspect Operating Income Open source 2007-11-01 – 2008-10-31: -4005831 USD Inspect Net Income Open source 2007-11-01 – 2008-10-31: 708305 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 26M 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-10-31	Revenue	3094072	Revenue: 3094072 Open source
20042004-10-31	Revenue	98767	Revenue: 98767 Open source
20052005-10-31	Revenue	8192	Revenue: 8192 Open source
20062006-10-31	Revenue	10516398	Revenue: 10516398 Open source
20072007-10-31	Revenue	23466311	Revenue: 23466311 Open source
20082008-10-31	Revenue	25959579	Revenue: 25959579 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

10.6% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20032003-10-31	Year over year	No prior comparable period	Revenue: 3094072 Open source
20042004-10-31	Year over year	-96.8%	Revenue: 98767 Open source Revenue: 3094072 Open source
20052005-10-31	Year over year	-91.7%	Revenue: 8192 Open source Revenue: 98767 Open source
20062006-10-31	Year over year	128,274%	Revenue: 10516398 Open source Revenue: 8192 Open source
20072007-10-31	Year over year	123.1%	Revenue: 23466311 Open source Revenue: 10516398 Open source
20082008-10-31	Year over year	10.6%	Revenue: 25959579 Open source Revenue: 23466311 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -12.1% 2008

Net margin -15.4% 2008

Free cash flow margin -18.7% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20032003-10-31	Operating margin	-11.2%	Operating Income: -347677 Open source Revenue: 3094072 Open source
20042004-10-31	Operating margin	-796.2%	Operating Income: -786415 Open source Revenue: 98767 Open source
20052005-10-31	Operating margin	-23,334.5%	Operating Income: -1911565 Open source Revenue: 8192 Open source
20062006-10-31	Operating margin	-34.4%	Operating Income: -3619186 Open source Revenue: 10516398 Open source
20072007-10-31	Operating margin	-60.8%	Operating Income: -14270857 Open source Revenue: 23466311 Open source
20082008-10-31	Operating margin	-12.1%	Operating Income: -3144385 Open source Revenue: 25959579 Open source
20032003-10-31	Net margin	-33.4%	Net Income: -1032453 Open source Revenue: 3094072 Open source
20042004-10-31	Net margin	-1,138.4%	Net Income: -1124336 Open source Revenue: 98767 Open source
20052005-10-31	Net margin	-35,537.8%	Net Income: -2911260 Open source Revenue: 8192 Open source
20062006-10-31	Net margin	-81.5%	Net Income: -8571021 Open source Revenue: 10516398 Open source
20072007-10-31	Net margin	-88.9%	Net Income: -20857884 Open source Revenue: 23466311 Open source
20082008-10-31	Net margin	-15.4%	Net Income: -4005831 Open source Revenue: 25959579 Open source
20032003-10-31	Free cash flow margin	Not reported	Revenue: 3094072 Open source Operating Cash Flow: -324361 Open source
20042004-10-31	Free cash flow margin	-651.9%	Revenue: 98767 Open source Operating Cash Flow: -640397 Open source Capital Expenditure: 3499 Open source
20052005-10-31	Free cash flow margin	-30,467.5%	Revenue: 8192 Open source Operating Cash Flow: -2258086 Open source Capital Expenditure: 237809 Open source
20062006-10-31	Free cash flow margin	-53.4%	Revenue: 10516398 Open source Operating Cash Flow: -5165425 Open source Capital Expenditure: 447939 Open source
20072007-10-31	Free cash flow margin	-18.7%	Revenue: 23466311 Open source Operating Cash Flow: -3683386 Open source Capital Expenditure: 709593 Open source
20082008-10-31	Free cash flow margin	Not reported	Revenue: 25959579 Open source Capital Expenditure: 708305 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -3.7M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-10-31	Operating cash flow	-324361	Operating Cash Flow: -324361 Open source
20042004-10-31	Operating cash flow	-640397	Operating Cash Flow: -640397 Open source
20052005-10-31	Operating cash flow	-2258086	Operating Cash Flow: -2258086 Open source
20062006-10-31	Operating cash flow	-5165425	Operating Cash Flow: -5165425 Open source
20072007-10-31	Operating cash flow	-3683386	Operating Cash Flow: -3683386 Open source
20082008-10-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -4.4M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-10-31	Free cash flow	Unavailable	Operating Cash Flow: -324361 Open source
20042004-10-31	Free cash flow	-643896	Operating Cash Flow: -640397 Open source Capital Expenditure: 3499 Open source
20052005-10-31	Free cash flow	-2495895	Operating Cash Flow: -2258086 Open source Capital Expenditure: 237809 Open source
20062006-10-31	Free cash flow	-5613364	Operating Cash Flow: -5165425 Open source Capital Expenditure: 447939 Open source
20072007-10-31	Free cash flow	-4392979	Operating Cash Flow: -3683386 Open source Capital Expenditure: 709593 Open source
20082008-10-31	Free cash flow	Unavailable	Capital Expenditure: 708305 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

77.6% 2008

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2003-10-31	Liabilities / assets	Not reported	Total Assets: 2210696 Open source
2004-10-31	Liabilities / assets	Not reported	No source recorded
20052005-10-31	Liabilities / assets	33.2%	Total Liabilities: 5607804 Open source Total Assets: 16911555 Open source
20062006-10-31	Liabilities / assets	66.3%	Total Liabilities: 25779163 Open source Total Assets: 38882650 Open source
20072007-10-31	Liabilities / assets	134.7%	Total Liabilities: 31438023 Open source Total Assets: 23333897 Open source
20082008-10-31	Liabilities / assets	77.6%	Total Liabilities: 17344616 Open source Total Assets: 22346110 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.53× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20032003-10-31	Current assets / current liabilities	0.01×	Current Assets: 46346 Open source Current Liabilities: 3707993 Open source
20042004-10-31	Current assets / current liabilities	0.19×	Current Assets: 700612 Open source Current Liabilities: 3779939 Open source
20052005-10-31	Current assets / current liabilities	0.05×	Current Assets: 270438 Open source Current Liabilities: 5607804 Open source
20062006-10-31	Current assets / current liabilities	0.59×	Current Assets: 7730447 Open source Current Liabilities: 13019162 Open source
20072007-10-31	Current assets / current liabilities	0.22×	Current Assets: 5559897 Open source Current Liabilities: 25018166 Open source
20082008-10-31	Current assets / current liabilities	0.53×	Current Assets: 7165384 Open source Current Liabilities: 13500545 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2003 2002-11-01 – 2003-10-31	−USD 1.03 million Exact value Exact value: -1032453 USD 2002-11-01 – 2003-10-31: -1032453 USD Inspect Net Income Open source Share or cite Citation for Net Income · Synovics Pharmaceuticals · 2003-10-31 Synovics Pharmaceuticals (edgar:1030839) Net Income: -1032453 USD Concept: fundies:NetIncome Period: 2002-11-01 to 2003-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3ANetIncome&period=2003-10-31&surface=latest&period_type=duration&start=2002-11-01&unit=USD&dimensions= Input fundies:NetIncome: -1032453 USD (2002-11-01 to 2003-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-06-000620.txt#3773 The citation records this snapshot. The page link may show a newer release later.	−USD 324,361 Exact value Exact value: -324361 USD 2002-11-01 – 2003-10-31: -324361 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Synovics Pharmaceuticals · 2003-10-31 Synovics Pharmaceuticals (edgar:1030839) Operating Cash Flow: -324361 USD Concept: fundies:OperatingCashFlow Period: 2002-11-01 to 2003-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3AOperatingCashFlow&period=2003-10-31&surface=latest&period_type=duration&start=2002-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -324361 USD (2002-11-01 to 2003-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-06-000620.txt#3398 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2003-11-01 – 2004-10-31	−USD 1.12 million Exact value Exact value: -1124336 USD 2003-11-01 – 2004-10-31: -1124336 USD Inspect Net Income Open source Share or cite Citation for Net Income · Synovics Pharmaceuticals · 2004-10-31 Synovics Pharmaceuticals (edgar:1030839) Net Income: -1124336 USD Concept: fundies:NetIncome Period: 2003-11-01 to 2004-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3ANetIncome&period=2004-10-31&surface=latest&period_type=duration&start=2003-11-01&unit=USD&dimensions= Input fundies:NetIncome: -1124336 USD (2003-11-01 to 2004-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-07-001236.txt#3494 The citation records this snapshot. The page link may show a newer release later.	−USD 640,397 Exact value Exact value: -640397 USD 2003-11-01 – 2004-10-31: -640397 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Synovics Pharmaceuticals · 2004-10-31 Synovics Pharmaceuticals (edgar:1030839) Operating Cash Flow: -640397 USD Concept: fundies:OperatingCashFlow Period: 2003-11-01 to 2004-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3AOperatingCashFlow&period=2004-10-31&surface=latest&period_type=duration&start=2003-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -640397 USD (2003-11-01 to 2004-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-07-001236.txt#3527 The citation records this snapshot. The page link may show a newer release later.	USD 3,499 Exact value Exact value: 3499 USD 2003-11-01 – 2004-10-31: 3499 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Synovics Pharmaceuticals · 2004-10-31 Synovics Pharmaceuticals (edgar:1030839) Capital Expenditure: 3499 USD Concept: fundies:CapitalExpenditure Period: 2003-11-01 to 2004-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3ACapitalExpenditure&period=2004-10-31&surface=latest&period_type=duration&start=2003-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3499 USD (2003-11-01 to 2004-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-07-001236.txt#3531 The citation records this snapshot. The page link may show a newer release later.	−USD 643,896 Calculation and evidence -640397 − 3499 USD Exact free cash flow: -643896 USD 2003-11-01 – 2004-10-31: -640397 USD · Inspect Operating Cash Flow · Source 2003-11-01 – 2004-10-31: 3499 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Synovics Pharmaceuticals · 2004-10-31 Synovics Pharmaceuticals (edgar:1030839) Free cash flow: -643896 USD Concept: free-cash-flow Period: 2003-11-01 to 2004-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -640397 USD (2003-11-01 to 2004-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-07-001236.txt#3527 Input fundies:CapitalExpenditure: 3499 USD (2003-11-01 to 2004-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-07-001236.txt#3531 The citation records this snapshot. The page link may show a newer release later.
2005 2004-11-01 – 2005-10-31	−USD 2.91 million Exact value Exact value: -2911260 USD 2004-11-01 – 2005-10-31: -2911260 USD Inspect Net Income Open source Share or cite Citation for Net Income · Synovics Pharmaceuticals · 2005-10-31 Synovics Pharmaceuticals (edgar:1030839) Net Income: -2911260 USD Concept: fundies:NetIncome Period: 2004-11-01 to 2005-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3ANetIncome&period=2005-10-31&surface=latest&period_type=duration&start=2004-11-01&unit=USD&dimensions= Input fundies:NetIncome: -2911260 USD (2004-11-01 to 2005-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-08-000932.txt#4066 The citation records this snapshot. The page link may show a newer release later.	−USD 2.26 million Exact value Exact value: -2258086 USD 2004-11-01 – 2005-10-31: -2258086 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Synovics Pharmaceuticals · 2005-10-31 Synovics Pharmaceuticals (edgar:1030839) Operating Cash Flow: -2258086 USD Concept: fundies:OperatingCashFlow Period: 2004-11-01 to 2005-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3AOperatingCashFlow&period=2005-10-31&surface=latest&period_type=duration&start=2004-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2258086 USD (2004-11-01 to 2005-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-07-001236.txt#3527 The citation records this snapshot. The page link may show a newer release later.	USD 237,809 Exact value Exact value: 237809 USD 2004-11-01 – 2005-10-31: 237809 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Synovics Pharmaceuticals · 2005-10-31 Synovics Pharmaceuticals (edgar:1030839) Capital Expenditure: 237809 USD Concept: fundies:CapitalExpenditure Period: 2004-11-01 to 2005-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3ACapitalExpenditure&period=2005-10-31&surface=latest&period_type=duration&start=2004-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 237809 USD (2004-11-01 to 2005-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-07-001236.txt#3531 The citation records this snapshot. The page link may show a newer release later.	−USD 2.5 million Calculation and evidence -2258086 − 237809 USD Exact free cash flow: -2495895 USD 2004-11-01 – 2005-10-31: -2258086 USD · Inspect Operating Cash Flow · Source 2004-11-01 – 2005-10-31: 237809 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Synovics Pharmaceuticals · 2005-10-31 Synovics Pharmaceuticals (edgar:1030839) Free cash flow: -2495895 USD Concept: free-cash-flow Period: 2004-11-01 to 2005-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2258086 USD (2004-11-01 to 2005-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-07-001236.txt#3527 Input fundies:CapitalExpenditure: 237809 USD (2004-11-01 to 2005-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-07-001236.txt#3531 The citation records this snapshot. The page link may show a newer release later.
2006 2005-11-01 – 2006-10-31	−USD 8.57 million Exact value Exact value: -8571021 USD 2005-11-01 – 2006-10-31: -8571021 USD Inspect Net Income Open source Share or cite Citation for Net Income · Synovics Pharmaceuticals · 2006-10-31 Synovics Pharmaceuticals (edgar:1030839) Net Income: -8571021 USD Concept: fundies:NetIncome Period: 2005-11-01 to 2006-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3ANetIncome&period=2006-10-31&surface=latest&period_type=duration&start=2005-11-01&unit=USD&dimensions= Input fundies:NetIncome: -8571021 USD (2005-11-01 to 2006-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#17938 The citation records this snapshot. The page link may show a newer release later.	−USD 5.17 million Exact value Exact value: -5165425 USD 2005-11-01 – 2006-10-31: -5165425 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Synovics Pharmaceuticals · 2006-10-31 Synovics Pharmaceuticals (edgar:1030839) Operating Cash Flow: -5165425 USD Concept: fundies:OperatingCashFlow Period: 2005-11-01 to 2006-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3AOperatingCashFlow&period=2006-10-31&surface=latest&period_type=duration&start=2005-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5165425 USD (2005-11-01 to 2006-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-08-000932.txt#4200 The citation records this snapshot. The page link may show a newer release later.	USD 447,939 Exact value Exact value: 447939 USD 2005-11-01 – 2006-10-31: 447939 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Synovics Pharmaceuticals · 2006-10-31 Synovics Pharmaceuticals (edgar:1030839) Capital Expenditure: 447939 USD Concept: fundies:CapitalExpenditure Period: 2005-11-01 to 2006-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3ACapitalExpenditure&period=2006-10-31&surface=latest&period_type=duration&start=2005-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 447939 USD (2005-11-01 to 2006-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#18266 The citation records this snapshot. The page link may show a newer release later.	−USD 5.61 million Calculation and evidence -5165425 − 447939 USD Exact free cash flow: -5613364 USD 2005-11-01 – 2006-10-31: -5165425 USD · Inspect Operating Cash Flow · Source 2005-11-01 – 2006-10-31: 447939 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Synovics Pharmaceuticals · 2006-10-31 Synovics Pharmaceuticals (edgar:1030839) Free cash flow: -5613364 USD Concept: free-cash-flow Period: 2005-11-01 to 2006-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5165425 USD (2005-11-01 to 2006-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-08-000932.txt#4200 Input fundies:CapitalExpenditure: 447939 USD (2005-11-01 to 2006-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#18266 The citation records this snapshot. The page link may show a newer release later.
2007 2006-11-01 – 2007-10-31	−USD 20.86 million Exact value Exact value: -20857884 USD 2006-11-01 – 2007-10-31: -20857884 USD Inspect Net Income Open source Share or cite Citation for Net Income · Synovics Pharmaceuticals · 2007-10-31 Synovics Pharmaceuticals (edgar:1030839) Net Income: -20857884 USD Concept: fundies:NetIncome Period: 2006-11-01 to 2007-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3ANetIncome&period=2007-10-31&surface=latest&period_type=duration&start=2006-11-01&unit=USD&dimensions= Input fundies:NetIncome: -20857884 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#17938 The citation records this snapshot. The page link may show a newer release later.	−USD 3.68 million Exact value Exact value: -3683386 USD 2006-11-01 – 2007-10-31: -3683386 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Synovics Pharmaceuticals · 2007-10-31 Synovics Pharmaceuticals (edgar:1030839) Operating Cash Flow: -3683386 USD Concept: fundies:OperatingCashFlow Period: 2006-11-01 to 2007-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3AOperatingCashFlow&period=2007-10-31&surface=latest&period_type=duration&start=2006-11-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3683386 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-08-000932.txt#4200 The citation records this snapshot. The page link may show a newer release later.	USD 709,593 Exact value Exact value: 709593 USD 2006-11-01 – 2007-10-31: 709593 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Synovics Pharmaceuticals · 2007-10-31 Synovics Pharmaceuticals (edgar:1030839) Capital Expenditure: 709593 USD Concept: fundies:CapitalExpenditure Period: 2006-11-01 to 2007-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3ACapitalExpenditure&period=2007-10-31&surface=latest&period_type=duration&start=2006-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 709593 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#18266 The citation records this snapshot. The page link may show a newer release later.	−USD 4.39 million Calculation and evidence -3683386 − 709593 USD Exact free cash flow: -4392979 USD 2006-11-01 – 2007-10-31: -3683386 USD · Inspect Operating Cash Flow · Source 2006-11-01 – 2007-10-31: 709593 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Synovics Pharmaceuticals · 2007-10-31 Synovics Pharmaceuticals (edgar:1030839) Free cash flow: -4392979 USD Concept: free-cash-flow Period: 2006-11-01 to 2007-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3683386 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-08-000932.txt#4200 Input fundies:CapitalExpenditure: 709593 USD (2006-11-01 to 2007-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#18266 The citation records this snapshot. The page link may show a newer release later.
2008 2007-11-01 – 2008-10-31	−USD 4.01 million Exact value Exact value: -4005831 USD 2007-11-01 – 2008-10-31: -4005831 USD Inspect Net Income Open source Share or cite Citation for Net Income · Synovics Pharmaceuticals · 2008-10-31 Synovics Pharmaceuticals (edgar:1030839) Net Income: -4005831 USD Concept: fundies:NetIncome Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3ANetIncome&period=2008-10-31&surface=latest&period_type=duration&start=2007-11-01&unit=USD&dimensions= Input fundies:NetIncome: -4005831 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#17938 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 708,305 Exact value Exact value: 708305 USD 2007-11-01 – 2008-10-31: 708305 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Synovics Pharmaceuticals · 2008-10-31 Synovics Pharmaceuticals (edgar:1030839) Capital Expenditure: 708305 USD Concept: fundies:CapitalExpenditure Period: 2007-11-01 to 2008-10-31 Values: Latest reported Published: 2026-11-03T00:16:08Z Snapshot: 5f3f7bdb223066ae76db77d16abf0e97702b793d1dd9cebd2749b41c154fc7cb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1030839/explain?concept=fundies%3ACapitalExpenditure&period=2008-10-31&surface=latest&period_type=duration&start=2007-11-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 708305 USD (2007-11-01 to 2008-10-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1030839/0000930413-09-003196.txt#18266 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

49 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-03. Source filing dates and reporting periods are shown separately.

Identifiers: 0001030839, 1030839, edgar:1030839

Also known as BIONUTRICS INC

Synovics Pharmaceuticals

Latest quarter

Revenue

Operating margin

Trailing twelve months

Revenue

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Capital expenditure

Where revenue goes

2008 2007-11-01 – 2008-10-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation